Quest Diagnostics (DGX) Revenue — Quarter Ended Mar 31, 2024
Revenue for the quarter increased compared to both the immediately preceding quarter and the same quarter one year earlier. The sequential growth reflects a continuation of the upward trend observed in recent periods.
Key takeaway
Quarter ended Mar 31, 2024 · FY2024 Q1
Revenue for the quarter increased compared to both the immediately preceding quarter and the same quarter one year earlier. The sequential growth reflects a continuation of the upward trend observed in recent periods.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$2.4B
Revenue reported for this quarter.
Quarter-over-quarter
+3.4%
Change from the immediately preceding quarter.
Year-over-year
+1.5%
Change from the comparable year-ago quarter.
Trailing four quarters
$9.3B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2023 | $2.3B | -4.7% |
| Sep 30, 2023 | $2.3B | -7.7% |
| Dec 31, 2023 | $2.3B | -1.9% |
| Mar 31, 2024 | $2.4B | +1.5% |
Revenue performance
Revenue rose from the prior quarter, while also showing a positive comparison with the year-ago period. The filing context does not provide specific drivers for the revenue change.
Quarterly comparison
Compared with the immediately preceding quarter, revenue increased. Compared with the same quarter one year earlier, revenue also grew. The trend data shows a recovery from prior declines.
What to watch
Days sales outstanding remained unchanged from the prior quarter but was higher than a year ago, which may indicate a shift in collection efficiency.